{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033514","form_type":"8-K","ticker":"AIM","cik":"0000946644","company_name":"AIM ImmunoTech Inc.","filed_at":"2026-07-16T20:05:43+00:00","discovered_at":"2026-07-16T20:07:00.304056+00:00","generated_at":"2026-07-16T20:07:11.246292+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"AIM ImmunoTech shareholders approve reverse stock split and warrant/note conversion issuances","bullets":["Special meeting held July 15, 2026; quorum of 10,671,690 shares (38.5%) present.","Proposals 1-5 approved: issuance of >19.99% of shares upon exercise of Class H, I, J warrants and conversion of two promissory notes.","Proposal 6 approved: reverse stock split at ratio up to 1-for-25, ratio at Board discretion.","Proposal 7 approved: adjournment if needed to solicit additional proxies."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033514","json":"https://secwatch.observer/filing/0001493152-26-033514.json","markdown":"https://secwatch.observer/filing/0001493152-26-033514.md","text":"https://secwatch.observer/filing/0001493152-26-033514.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/946644/000149315226033514/0001493152-26-033514-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/946644/000149315226033514/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T20:07:11.246292+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}